1991
DOI: 10.1016/0006-291x(91)91911-u
|View full text |Cite
|
Sign up to set email alerts
|

In vivo oxygen-17 nuclear magnetic resonance for the estimation of cerebral blood flow and oxygen consumption

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
40
0
1

Year Published

1997
1997
2005
2005

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 50 publications
(44 citation statements)
references
References 9 publications
3
40
0
1
Order By: Relevance
“…This linear relationship was in fact shown in our previous experiments based on invasive methods that allowed the continuous in vivo measurement of C a (t) (Zhu et al, 2002). It is also supported by other studies (Arai et al, 1991;Pekar et al, 1991). Substituting Eq.…”
Section: Simplified Model: Methods Isupporting
confidence: 85%
See 1 more Smart Citation
“…This linear relationship was in fact shown in our previous experiments based on invasive methods that allowed the continuous in vivo measurement of C a (t) (Zhu et al, 2002). It is also supported by other studies (Arai et al, 1991;Pekar et al, 1991). Substituting Eq.…”
Section: Simplified Model: Methods Isupporting
confidence: 85%
“…However, this is a complex measurement. It requires independent determinations of cerebral H 2 15 O content, CBF, and H 2 15 O present in the arterial supply to the brain (the arterial input function) (Mintun et al, 1984); in addition, it is necessary to experimentally determine (Mintun et al, 1984) or make assumptions (Ohta et al, 1992) (Arai et al, 1990(Arai et al, , 1991Fiat and Kang, 1992;Mateescu et al, 1989;Pekar et al, 1991Pekar et al, , 1995Zhu et al, 2002). This is analogous to the PET approach.…”
mentioning
confidence: 99%
“…In vivo 17 O approaches can be potentially applied to measuring and imaging two important physiological parameters, namely CMRO 2 and CBF. 6,8,14,16,[37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54] The 17 O NMR approaches for in vivo determinations of CMRO 2 and CBF involve the measurement of (i) the amount of 17 O-labeled water metabolically generated from the inhaled 17 O 2 gas through the oxidative pathway, and (ii) the washout rate of the 17 O-labeled water tracer introduced by a bolus injection, respectively. In terms of methodology, there is a close similarity between the in vivo 17 O approaches and PET approaches, especially for CBF measurements.…”
Section: H Relaxation In Watermentioning
confidence: 99%
“…Another common and more straightforward approach for detecting the 17 Owing to the relatively low inherent NMR sensitivity of 17 O NMR detection and the small amount of metabolic water generated during an 17 O 2 inhalation, most of the early 17 O MR studies on oxidative metabolism detected the metabolic H 2 17 O from a large volume in living animal 42,49,50,82 and human brains, 8 as well as whole living insects. 83 To achieve a better spatial localization, techniques that are frequently applied for the proton MRI (e.g.…”
Section: Direct In Vivo 17 O Nmr Approachmentioning
confidence: 99%
See 1 more Smart Citation